Zentiva
Zentiva (BVB: SCD), is an international pharmaceutical company focused on developing, manufacturing and marketing modern generic pharmaceutical products. The Company has leading positions in the pharmaceutical markets in the Czech Republic, Slovakia, Romania, and Turkey and is growing in Poland, Russia, Bulgaria, Hungary, Ukraine and the Baltic States. Zentiva’s strategy is to further this growth by increasing patient access to modern medicines through primary care providers within the EU and Eastern Europe.
History of Zentiva
- The Black eagle, "U černého orla" pharmacy in Prague is purchased by Benjamin and Karel Fragner in 1857.
- First factory at Dolní Měcholupy in 1930
- Nationalization by the Czech government in 1946
- Generic strategy in 1998
- Acquisition of Leciva Slovakofarma, main pharmaceutical company of Slovakia[1]
Generic strategy of Sanofi
Zentiva is the generic drug arm of sanofi since 2009. The Company addresses a wide range of therapeutic areas but has a particular focus on cardiovascular disorders, inflammatory conditions, pain, infections and diseases of the central nervous system and the gastrointestinal and urology fields. The Zentiva Group employs almost 6,000 people and has production sites in the Czech Republic, Slovakia, Romania, and Turkey.
External links
References